Reliq Health Technologies Inc V.RHT

Reply from Scott yw

[Peggy123]

Filing the financials is the top priority for the Company.  As has been disclosed, management lost 2 weeks due to the private placement occurring during the audit working period and it has been slower than expected receiving the additional audit documentation from and calls with customers that KPMG requested.  Those are now done so the audit should be completed shortly.

 

As for your other comment, I disagree that you could find a more compelling Company to invest in, not only in this space but in any market segment.  If I were a new investor looking at the chart and the fundamentals, I would consider Reliq as significantly undervalued.  The Company doubled revenue the last 2 years, signed 4 major health providers in the US in the last year, have over 500k patients in the pipeline worth over $100 million dollars in future annual revenue, operate in a market worth $100 billion, had an oversubscribed $5 million raise that sold out in hours with primarily institutions, raised $5 million (12% dilution) to add $20 million in annual recurring revenue by the end of 2024 at 70% GM and 40% Ebitda margin (50%-200% increase in market cap potential).  If you are new to the stock or long, the only current negatives are the high AR balance and the late financials.  Once those are shown are resolved, the stock price should reach its actual value.  It may take a few months for the stock price to recover but the Reliq Management team is building a business with long term value for shareholders that also provides urgently needed care to those with the least access or highest needs.

 

Best Regards,

 

Scott

 

Scott Fitzgerald

Investor Relations

Reliq Health Technologies, Inc.

Show quoted text